A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Medicines Agency accepts GSK's marketing authorization application for momelotinib for the treatment of myelofibrosis, a type of bone marrow cancer; myelofibrosis affects approximately 20,000 patients in the US

Regeneron reports FDA has accepted its sBLA for Evkeeza evinacumab-dgnb for priority review; Evkeeza treats children with ultra-rare inherited homozygous familial hypercholesterolemia, a form of high cholesterol

AstraZeneca showcases strength of hematology portfolio and pipeline across multiple hard-to-treat conditions at ASH 2022 December 10-13; eight approved and potential new medicines to be featured across more than 10 types of blood cancers and rare diseases

Roche receives Canadian approval for injectable Polivy polatuzumab vedotin to treat B-cell lymphoma; drug used in combination with Rituxan rituximab, cyclophosphamide, doxorubicin and immunosuppressive drug prednisone

FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count